Intestinal Polyposis: Clinical Trials

5 trials for Intestinal Polyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
JNJ-64251330 - Adenomatous Polyposis Coli
Phase 1CompletedJanssen Research & Development, LLC422021-11-102023-06-02
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Guselkumab, Placebo - Adenomatous Polyposis Coli
Phase 1CompletedJanssen Research & Development, LLC772018-11-192025-02-03
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
Bevacizumab-IRDye800CW, Near infrared fluorescence endoscopy platform - Adenomatous Polyposis Coli
Phase 1CompletedUniversity Medical Center Groningen172014-03-012023-10-27
Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)
Black raspberry (BRB) Slurry, Black Raspberry (BRB) Suppositories, Black Raspberry (BRB) Placebo Slurry - Familial Adenomatous Polyposis
Phase 1CompletedThe Cleveland Clinic342005-12-012016-02-15
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
celecoxib, placebo - Colorectal Cancer, Precancerous Condition
Phase 1CompletedM.D. Anderson Cancer Center222002-11-212018-11-07

Narrower conditions

Adenomatous Polyposis Coli (5)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Polyps (1)  ·  Precancerous Conditions (1)  ·  Rectal Neoplasms (1)

Broader conditions

Adenoma (5)  ·  Adenomatous Polyps (5)  ·  Colonic Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)  ·  Genetic Diseases, Inborn (5)  ·  Intestinal Diseases (5)  ·  Intestinal Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)

Interventions

Celecoxib (1)  ·  Suppositories (1)  ·  guselkumab (1)

Sponsors

Janssen Research & Development, LLC (2)  ·  M.D. Anderson Cancer Center (1)  ·  The Cleveland Clinic (1)  ·  University Medical Center Groningen (1)

Countries

United States (4)  ·  Netherlands (3)  ·  France (2)  ·  Germany (2)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Israel (1)  ·  Poland (1)  ·  South Korea (1)  ·  Sweden (1)

Top investigators

Carol A Burke, MD (1)  ·  Jan H Kleibeuker, MD, senior full professor (1)  ·  Jan Jakob Koornstra, MD PhD (1)  ·  Patrick M. Lynch, MD, JD (1)  ·  Wouter B Nagengast, PharmD MD PhD (1)

Results publications

PMID 20234350, PMID 37119510

NIH funding

2019 (1)